Skip to Content

APO IMA 400 (Imatinib Mesylate 400 mg)

Pill with imprint APO IMA 400 is Orange, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Apotex Corp..

Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO IMA 400

Imatinib Mesylate

Imprint:
APO IMA 400
Strength:
400 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
National Drug Code (NDC):
60505-2901

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide